[Endocrine-metabolic peculiarities in women of reproductive age with hyperplastic processes of cervix and mammary glands].
The aim of our investigation was the detection of endocrine-metabolic disorders in patients with hyperplastic processes of endomyometrium, uterine cervix and mammary glands. 88 patients of reproductive age with several gynaecological complaints have been investigated. 72 patients with hyperplastic processes in endomyometrium, uterine cervix (hyperplasia, polyposis, myoma) and mammary glands (fibroadenomatosis, adenomatosis) were selected in main group. Control group consisted of 16 patients without any hyperplastic processes of reproductive organs. Metabolic syndrome in main group was revealed in 28% of cases, in control - 18,8% (chi(2)=3,95, p=0,047); insulin resistance - 37,5% and 18,7% (chi(2)=4,59, p=0,033), respectively; obesity - 52,8% and 25,0% (chi(2)=4,05, p=0,045), respectively; dyslipidemia - 52,8% and 0,0%; hypertension - 26,4% and 12,5% (chi(2)=1,88, p=NS), respectively. Blood leptin level in main group was - 13,7+/-10,9 ng/ml, and in control - 5,0+/-2,9 ng/ml (p=0,005). Our results suggest that metabolic syndrome and its components significantly influences the formation of hyperplastic processes of endomyometrium, uterine cervix and mammary glands. Blood leptin level is significantly increased in patients with hyperplastic pathologies.
Kadzhaia
N R
NR
Virsaladze
D K
DK
Tkeshelashvili
B D
BD
Dzhavashvili
L V
LV
Dzhugeli
M K
MK
D000328:Adult; D001943:Breast Neoplasms / Q000150:complications / Q000473:pathology*; D002584:Cervix Uteri / Q000473:pathology; D004700:Endocrine System Diseases / Q000150:complications / Q000175:diagnosis*; D005260:Female; D006801:Humans; D006965:Hyperplasia; D020738:Leptin / Q000097:blood; D042361:Mammary Glands, Human / Q000473:pathology; D024821:Metabolic Syndrome / Q000150:complications / Q000175:diagnosis*; D012098:Reproduction; D002583:Uterine Cervical Neoplasms / Q000150:complications / Q000473:pathology*
D020738:Leptin